Abstract
A patient with rheumatoid arthritis developed severe exacerbation of symptoms 18 hours after an injection of gold thiomalate (sodium aurothiomalate). Immune complexes were present in his serum and synovial fluid; in the synovial fluid they were associated with intense complement activation. The effect of gold salts on splenic reticuloendothelial function was determined by measuring the clearance of heat-damaged erythrocytes from the circulation. Gold thiomalate (50 mg) substantially delayed clearance in the patient but had no effect in four other patients with rheumatoid arthritis who had not had a postinjection reaction. Severely impaired clearance also occurred in three out of four healthy people given 100 mg gold but they remained asymptomatic. The postinjection reaction may be an immune-complex disease that is triggered in certain patients because gold transiently inhibits reticuloendothelial function.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bluestone R., Cracchiolo A., 3rd, Goldberg L. S., Pearson C. M. Catabolism and synovial transport of rheumatoid factor. Ann Rheum Dis. 1970 Jan;29(1):47–55. doi: 10.1136/ard.29.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowring C. S., Glass H. I., Lewis S. M. Rate of clearance by the spleen of heat-damaged erythrocytes. J Clin Pathol. 1976 Sep;29(9):852–854. doi: 10.1136/jcp.29.9.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cahill R. N. Effect of sodium aurothiomalate "mycrosin" on DNA synthesis in phytohaemagglutin-stimulated cultures of sheep lymphocytes. Experientia. 1971 Aug;27(8):913–914. doi: 10.1007/BF02135740. [DOI] [PubMed] [Google Scholar]
- Cochrane C. G., Koffler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16(0):185–264. doi: 10.1016/s0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
- Ghadially F. N., DeCoteau W. E., Huang S., Thomas I. Ultrastructure of the skin of patients treated with sodium aurothiomalate. J Pathol. 1978 Feb;124(2):77–83. doi: 10.1002/path.1711240203. [DOI] [PubMed] [Google Scholar]
- Halla J. T., Hardin J. G., Linn J. E. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts. Arthritis Rheum. 1977 Jul-Aug;20(6):1188–1191. doi: 10.1002/art.1780200605. [DOI] [PubMed] [Google Scholar]
- Harth M., Stiller C. R., St C Sinclair N. R., Evans J., McGirr D., Zuberi R. Effects of a gold salt on lymphocyte responses. Clin Exp Immunol. 1977 Feb;27(2):357–364. [PMC free article] [PubMed] [Google Scholar]
- Jayson M. I., Barks J. S. Oedema in rheumatoid arthritis: changes in the coefficient of capillary filtration. Br Med J. 1971 Jun 5;2(5761):555–557. doi: 10.1136/bmj.2.5761.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jessop J. D., Vernon-Roberts B., Harris J. Effects of gold salts and prednisolone on inflammatory cells. I. Phagocytic activity of macrophages and polymorphs in inflammatory exudates studied by a "skin-window" technique in rheumatoid and control patients. Ann Rheum Dis. 1973 Jul;32(4):294–300. doi: 10.1136/ard.32.4.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lies R. B., Cardin C., Paulus H. E. Inhibition by gold of human lymphocyte stimulation. An in vitro study. Ann Rheum Dis. 1977 Jun;36(3):216–218. doi: 10.1136/ard.36.3.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lipsky P. E., Ziff M. Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest. 1977 Mar;59(3):455–466. doi: 10.1172/JCI108660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marks J., Birkett D. A., Shuster S. "Capillary permeability" in patients with collagen vascular diseases. Br Med J. 1972 Mar 25;1(5803):782–784. doi: 10.1136/bmj.1.5803.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naot Y., Merchav S. Inhibition of mycoplasma-induced lymphocyte activation by sodium aurothiomalate. Infect Immun. 1978 Jul;21(1):340–341. doi: 10.1128/iai.21.1.340-341.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perrin L. H., Lambert P. H., Miescher P. A. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest. 1975 Jul;56(1):165–176. doi: 10.1172/JCI108065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pussell B. A., Lockwood C. M., Scott D. M., Pinching A. J., Peters D. K. Value of immune-complex assays in diagnosis and management. Lancet. 1978 Aug 12;2(8085):359–364. doi: 10.1016/s0140-6736(78)92954-9. [DOI] [PubMed] [Google Scholar]
- Ruddy S., Austen K. F. The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids. Arthritis Rheum. 1970 Nov-Dec;13(6):713–723. doi: 10.1002/art.1780130601. [DOI] [PubMed] [Google Scholar]
- Vernon-Roberts B., Doré J. L., Jessop J. D., Henderson W. J. Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients. Ann Rheum Dis. 1976 Dec;35(6):477–486. doi: 10.1136/ard.35.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zubler R. H., Nydegger U., Perrin L. H., Fehr K., McCormick J., Lambert P. H., Miescher P. A. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest. 1976 May;57(5):1308–1319. doi: 10.1172/JCI108399. [DOI] [PMC free article] [PubMed] [Google Scholar]
